financetom
Business
financetom
/
Business
/
Competition Commission clears Bharti AXA-ICICI Lombard deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Competition Commission clears Bharti AXA-ICICI Lombard deal
Nov 2, 2020 12:34 PM

The Competition Commission of India (CCI) on Monday said it has approved the acquisition of general insurance business of Bharti AXA by ICICI Lombard. Marking a major consolidation move in the insurance space, the proposed deal was announced in August this year.

Share Market Live

NSE

Pursuant to the proposed combination, the entire general insurance business of Bharti AXA would be transferred by way of a demerger to ICICI Lombard in consideration of issuance of shares by ICICI Lombard to Bharti AXA, an official release said. "Commission approves acquisition of General Insurance Business of Bharti AXA@BhartiAXAGI by ICICI Lombard @ICICILombard," the fair trade regulator said in a tweet.

A general insurance company, Bharti AXA is a joint venture between Bharti General Ventures Private Ltd and Societe Beaujon. ICICI Lombard is a general insurance company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Provident Healthcare Partners Advises Meperia in its Acquisition by Diversis Capital
Provident Healthcare Partners Advises Meperia in its Acquisition by Diversis Capital
Nov 20, 2025
BOSTON, Nov. 20, 2025 /PRNewswire/ -- Provident Healthcare Partners (Provident), a leading healthcare investment banking firm, is pleased to announce it has advised Meperia, a supply chain and strategic sourcing platform serving Integrated Delivery Networks (IDNs). Provident also facilitated Diversis in the acquisition of Kermit, a bill-only, spend management, and analytics platform for physician preference items (PPI). This transaction marks...
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Nov 20, 2025
Vanda Pharmaceuticals Inc. ( VNDA ) on Monday released topline results from its randomized controlled clinical study (VP-VLY-686-2601) evaluating tradipitant to prevent nausea and vomiting induced by Novo Nordisk A/S ( NVO ) Wegovy. • Get the market research on VNDA stock here. The trial studied 116 healthy overweight or obese adults. The study saw 29.3% of tradipitant-treated participants (17/58)...
Cemtrex to Acquire Invocon for $7.06 Million
Cemtrex to Acquire Invocon for $7.06 Million
Nov 20, 2025
01:59 PM EST, 11/20/2025 (MT Newswires) -- Cemtrex ( CETX ) said Thursday it has agreed to acquire Invocon, a Texas-based aerospace and defense engineering firm, for $7.06 million. The deal, which is subject to customary closing conditions, is expected to close on or around Jan. 1, 2026, the company said. After the acquisition closes, Cemtrex ( CETX ) plans...
Medexus Pharmaceuticals to Launch Normal Course Issuer Bid
Medexus Pharmaceuticals to Launch Normal Course Issuer Bid
Nov 20, 2025
01:58 PM EST, 11/20/2025 (MT Newswires) -- Medexus Pharmaceuticals ( MEDXF ) on Thursday said it received exchange approvals to launch a normal course issuer bid (NCIB).. The company may buy back for cancellation up to 2.98-million shares, about 10% of the public float. As of Nov. 12, the company had 32.4-million shares outstanding and a public float of 29.8-million...
Copyright 2023-2026 - www.financetom.com All Rights Reserved